It affects the digestive system and metabolism
K., Rychly, D
Wegovy tablets and injections are FDA-approved in adults for: weight loss and weight management in adults with obesity or adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) reducing major cardiovascular event risks (such as heart attack, stroke, or death) in adults with established CV disease and either obesity or overweight Wegovy injection is also FDA-approved for: weight loss and weight management patients with obesity who are 12 years and older non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), this is an accelerated approval
And per GLP-1 pharmacology, excess dietary carbohydrates can theoretically promote the insulin-secreting effects of GLP-1s which are not necessarily desirable
Es deutet auf ein energetisch reduziertes, unterfordertes oder starr reagierendes System hin
They are not for human consumption, medical treatment, diagnosis, disease prevention, or veterinary use